Neo-adjuvant organ-preserving chemotherapy in the management of locally advanced oral cavity and oropharynx cancer
1996-01-01 Mantovani, G; Gebbia, V; Proto, E; Cossu, F; Bianchi, A; Curreli, L; Ghiani, M; Astara, G; Lampis, B; Dessi, D; Santona, M; Massa, E
Second line chemotherapy for metastatic colorectal carcinoma: A phase II study with mitomycin C, adriamycin and lonidamine
1996-01-01 Gebbia, V.; Testa, A.; Cannata, G.; Tirrito, M. L.; Longo, A.; Sciume, C.; Valdesi, M.; Salamone, G.; Gebbia, N.; Leo, P.
Treatment of advanced adenocarcinomas of the exocrine pancreas and the gallbladder with 5-fluorouracil, high dose levofolinic acid and oral hydroxyurea on a weekly schedule. Results of a multicenter study of the Southern Italy Oncology Group (G.O.I.M.)
1996-01-01 Gebbia, V; Majello, E; Testa, A; Pezzella, G; Giuseppe, S; Giotta, F; Riccardi, F; Fortunato, S; Colucci, G; Gebbia, N.
Mitomycin C plus vindesine plus etoposide (MEV) versus mitomycin C plus vindesine plus cisplatin (MVP) in stage IV non-small-cell lung cancer: A phase III multicentre randomised trial. The "Gruppo Oncologico Centro-Sud-Isole' (G.O.C.S.I.)
1996-01-01 Gridelli, C; Perrone, F; Palmeri, S; D'Aprile, M; Cognetti, F; Rossi, A; Gebbia, V; Pepe, R; Veltri, E; Airoma, G; Russo, A; Incoronato, P; Scinto, Af; Palazzolo, G; Natali, M; Leonardi, V; Gallo, C; De Placido, S; Bianco, Ar.
Neo-adjuvant (primary) organ-preserving chemotherapy in the management of locally advanced laryngeal carcinoma
1996-01-01 Mantovani, G; Gebbia, V; Proto, E; Cossu, F; Bianchi, A; Curreli, L; Ghiani, M; Massa, E; Astara, G; Lampis, B; Dessi, D; Santona, M
Randomized phase II noncomparative trial of oral and intravenous doxifluridine plus levo-leucovorin in untreated patients with advanced colorectal carcinoma
1996-01-01 Bajetta, E; Di Bartolomeo, M; Somma, L; Moreschi, M; Comella, G; Turci, D; Gebbia, V; Scanni, A; Bordogna, G; Stampino, Cg.
Escalating doses of mitoxantrone with granulocyte colony-stimulating factor (G-CSF) rescue plus 5-fluorouracil and high-dose levofolinic acid in metastatic breast cancer
1994-01-01 Gebbia, V; Valenza, R; Testa, A; Cannata, G; Verderame, F; Gebbia, N.
Cisplatin and vinorelbine followed by ifosfamide plus epirubicin vs the opposite sequence in advanced unresectable stage III and metastatic stage IV non-small-cell lung cancer: a prospective randomized study of the Southern Italy Oncology Group (GOIM)
1997-01-01 Colucci, G; Gebbia, V; Galetta, D; Riccardi, F; Cariello, S; Gebbia, N.
Dose intensification of mitoxantrone in combination with levofolinic acid, fluorouracil, cyclophosphamide and granulocyte colony stimulating factor support in advanced untreated breast cancer patients. A multicentric phase II study of the Southern Italy Oncology Group
1997-01-01 Colucci, G.; Giotta, F.; Gebbia, V.; Riccardi, F.; Pezzella, G.; Durini, E.; Caruso, M.; Romito, S.; Gebbia, N.
Vinorelbine, cisplatin, and 5-fluorouracil as initial treatment for previously untreated, unresectable squamous cell carcinoma of the head and neck: results of a phase II multicenter study
1997-01-01 Gebbia, V; Mantovani, G; Farris, A; Agostara, B; Desogus, A; Curreli, L; Moschella, F; Di Gregorio, C; Bajetta, E; Gebbia, N
Cisplatin and epirubicin plus oral lonidamine as first-line treatment for metastatic breast cancer
1997-01-01 Gebbia, Vittorio; Borsellino, Nicolò; Testa, Antonio; Latteri, Mario Adelfio; Milia, Valerio; Valdesi, Matteo; Giotta, Francesco; Gebbia, Nicolò; Colucci, Giuseppe
FEP regimen (epidoxorubicin, etoposide and cisplatin) in advanced gastric cancer, with or without low-dose GM-CSF: an Italian Trial in Medical Oncology (ITMO) study.
1998-01-01 Bajetta, E; Di Bartolomeo, M; Carnaghi, C; Buzzoni, R; Mariani, L; Gebbia, V; Comella, G; Pinotti, G; Ianniello, G; Schieppati, G; Bochicchio, Am; Maiorino, L.
Standard interleukin-2 (IL-2) and interferon-alpha immunotherapy versus an IL-2 and 4-epirubicin immuno-chemotherapeutic association in metastatic renal cell carcinoma
1998-01-01 Naglieri, E; Gebbia, V; Durini, E; Lelli, G; Abbate, I; Selvaggi, Fp; Di Tonno, P; Colucci, G.
A phase II trial of etoposide, folinic acid, fluorouracil and epirubicin in advanced pancreatic carcinoma
1998-01-01 Maiello, E; Gebbia, V; Giuliani, F; Testa, A; Giotta, F; Gebbia, N; Colucci, G
Neo-adjuvant chemo-(immuno-)therapy of advanced squamous-cell head and neck carcinoma: a multicenter, phase III, randomized study comparing cisplatin + 5-fluorouracil (5-FU) with cisplatin + 5-FU + recombinant interleukin 2
1998-01-01 Mantovani, G; Gebbia, V; Airoldi, M; Bumma, C; Contu, P; Bianchi, A; Ghiani, M; Dessì, D; Massa, E; Curreli, L; Lampis, B; Lai, P; Mulas, C; Testa, A; Proto, E; Cadeddu, G; Tore, G
Mental nerve invasion by basal cell carcinoma of the chin: a case report
1998-01-01 Di Gregorio, C; Florena, Am; Gebbia, V; Moschella, F.
Single agent 2',2'-difluorodeoxycytidine in the treatment of metastatic urothelial carcinoma: a phase II study
1999-01-01 Gebbia, V; Testa, A; Borsellino, N; Mauceri, G; Varvara, F; Tirrito, M L; Sambataro, D; Fallica, G
5-fluorouracil and levofolinic acid with or without recombinant interferon-2b in patients with advanced colorectal carcinoma: a randomized multicenter study with stratification for tumor burden and liver involvement by the Southern Italy Oncology Group
1999-01-01 Colucci, G; Maiello, E; Gebbia, V; Giuliani, F; Serravezza, G; Lelli, G; Leo, S; Filippelli, G; Nicolella, G; Brandi, M.
Performance of Purpose-Built vs Off-Label Transcatheter Devices for Aortic Regurgitation
2024-01-01 Poletti, Enrico; Adam, Matti; Wienemann, Hendrik; Sisinni, Antonio; Patel, Kush P.; Amat-Santos, Ignacio J.; Orzalkiewicz, Mateusz; Saia, Francesco; Regazzoli, Damiano; Fiorina, Claudia; Panoulas, Vasileios; Brinkmann, Christina; Giordano, Arturo; Taramasso, Maurizio; Maisano, Francesco; Barbanti, Marco; De Backer, Ole; Van Mieghem, Nicolas M.; Latib, Azeem; Squillace, Mattia; Baldus, Stephan; Geyer, Martin; Baumbach, Andreas; Bedogni, Francesco; Rudolph, Tanja K.; Testa, Luca
Intracardiac Echocardiographic Probe Used Via Transesophageal to Guide Left Atrial Appendage Occlusion
2024-01-01 Laterra, Giulia; Sacchetta, Giorgio; Artale, Claudia; Barrano, Giombattista; Mazzone, Paolo; Ruscica, Giovanni; Guarneri, Maria Concetta; Costa, Serena; Barbanti, Marco; Contarini, Marco
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile
Scopri
Tipologia
- 1 Contributo su Rivista15361
- 4 Contributo in Atti di Convegno ...2
- 2 Contributo in Volume1
Data di pubblicazione
- In corso di stampa17
- 2020 - 20267032
- 2010 - 20195807
- 2000 - 20091967
- 1990 - 1999480
- 1980 - 198960
- 1979 - 19791
Editore
- Trans Tech Publications1
Rivista
- INTERNATIONAL JOURNAL OF MOLECULA...225
- JOURNAL OF CLINICAL MEDICINE153
- CANCERS122
- INTERNATIONAL JOURNAL OF ENVIRONM...110
- LNS. ACTIVITY REPORT85
- PHD KORE REVIEW78
- DIAGNOSTICS77
- RIVISTA DELLA COOPERAZIONE GIURID...76
- SCIENTIFIC REPORTS73
- SUSTAINABILITY72
Serie
- ADVANCED MATERIALS RESEARCH1
- WORKING PAPERS RES1
Keyword
- COVID-19257
- Humans250
- Female133
- Male127
- SARS-CoV-2108
- inflammation103
- oxidative stress85
- Italy78
- Adult69
- Middle Aged67
Lingua
- eng10818
- ita2584
- fre66
- spa64
- lat12
- ger11
- por6
- ara3
- cat3
- enm2
Accesso al fulltext
- no fulltext15364